An integrated approach for evaluating all clinically relevant fusions and rearrangements in B- and T-cell lymphomas:

• Accurately diagnose disease and classify subtypes

• Refine patient risk assessment to inform treatment decisions

• Choose the most effective therapy to optimize outcomes

This webinar will explore how 3D genomics can enhance diagnostic accuracy and uncover novel therapeutic targets in uterine sarcoma. Participants will gain insights into the advantages of 3D genomic approaches compared to traditional clinical next-generation sequencing (NGS) assays. Attendees will also learn about the implications of these advanced genomic techniques for clinical practice and patient care in gynecologic oncology.